- Respiratory Department of Daping Hospital, Third Military Medical University of Chinese PLA. Chongqing, 400042, China;
变应原特异性免疫治疗(SIT)是目前已知的唯一能改变变态反应性疾病患者对变应原免疫的类型,并有可能治愈变态反应性疾病的方法。通常是通过反复多次皮下注射,即皮下免疫治疗(SCIT),诱导患者对变应原的耐受,但因其不良反应较大,并有可能引起过敏性休克等原因而使其应用受到限制。近来通过舌下含服的方法进行免疫治疗,即舌下免疫治疗(SLIT),引起了临床上广泛的兴趣。与SCIT相比,SLIT完全由患者自己使用药物,因此更方便,临床研究也证实这种方法更安全,也更有效。而且与药物治疗相比,SLIT可以显著降低临床费用,减轻患者和社会的负担。但是SLIT诱导免疫耐受的确切机制目前仍不清楚。
Citation: WU Kui,BI Yutian,WANG Changzheng. Allergen specific sublingual immunotherapy. Chinese Journal of Respiratory and Critical Care Medicine, 2007, 6(5): 321-325. doi: Copy
1. | Passalacqua G,Guerra L,Pasquali M,et al.Efficacy and safety of sublingual immunotherapy.Ann Allergy Asthma Immunol,2004,93:3-12. |
2. | Bagnasco M,Passalacqua G,Villa G,et al.Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers.Clin Exp Allergy,2001,31:54-60. |
3. | Walker GF,Langoth N,Bernkop-Schnürch A.Peptidase activity on the surface of the porcine buccal mucosa,2002,233:141-147. |
4. | Bousquet J,Van Cauwenberge P,Khaltaev N,et al.Allergic rhinitis and its impact on asthma.J Allergy Clin Immunol,2001,108:S147-334. |
5. | Wilson DR,Lima MT,Durham SR.Sublingual immunotherapy for allergic rhinitis:systematic review and meta-analysis.Allergy,2005,60:4-12. |
6. | Lowenstein H,LarsenJN.Recombinant allergens/allergen standardization.Curr Allergy Asthma Rep,2001,1:474-479. |
7. | Moingeon P.Sublingual immunotherapy:from biological extracts to recombinant allergens.Allergy,2006,Suppl 81:15-19. |
8. | Baena-Cagnani CE,Passalacqua G,Baena-Cagnani RC,et al.Sublingual immunotherapy in pediatric patients:beyond clinical efficacy.Curr Opin Allergy Clin Immunol.2005,5:173-177. |
9. | Pajno GB,Morabito L,Barberio G,et al.Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites:a double-blind,placebo-controlled study.Allergy,2000,55:842-849. |
10. | Ippoliti F,De Santis W,Volterrani A,et al.Immunomodulation during sublingual therapy in allergic children.Pediatr Allergy Immunol,2003,14:216-221. |
11. | Rolinck-Werninghaus C,Wolf H,Liebke C,et al.A prospective,randomized,double-blind,placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy(SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.Allergy,2004,59:1285-1293. |
12. | Novembre E,Galli E,Landi F,et al.Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.J Allergy Clin Immunol,2004,114:851-857. |
13. | Di Rienzo V,Marcucci F,Puccinelli P,et al.Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite:a 10-year prospective study.Clin Exp Allergy,2003,33:206-210. |
14. | Tonnel AB,Scherpereel A,Douay B,et al.Allergic rhinitis due to house dust mites:evaluation of the efficacy of specific sublingual immunotherapy.Allergy,2004,59:491-497. |
15. | Berto P,Passalacqua G,Crimi N,et al.Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy:the Sublingual Immunotherapy Pollen Allergy Italy(SPAI) study.Ann Allergy Asthma Immunol,2006,97:615-621. |
16. | Calamita Z,Saconato H,Pela AB,et al.Efficacy of sublingual immunotherapy in asthma:systematic review of randomized-clinical trials using the Cochrane Collaboration method.Allergy,2006,61:1162-1172. |
17. | Malling HJ.Sublingual immunotherapy:efficacy--methodology and outcome of clinical trials.Allergy,2006,Suppl 81:24-28. |
18. | Wilson DR,Torres LI,Durham SR.Sublingual immunotherapy for allergic rhinitis(Cochrane review).Cochrane Database Syst Rev,2003,CD002893. |
19. | Marogna M,Bruno M,Massolo A,Falagiani P.Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity:A long-term(13-year) retrospective study in real life.Int Arch Allergy Immunol,2007,142:70-78. |
20. | Bordignon V,Burastero SE.Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis.Ann Allergy Asthma Immunol,2006,97:158-163. |
21. | Savolainen J,Jacobsen L,Valovirta E.Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.Allergy,2006,61:1184-1190. |
22. | Valovirta E,Jacobsen L,Ljørring C,et al.Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.Allergy,2006,61:1177-1183. |
23. | Frati F,Incorvaia C,Marcucci F,et al.Dose dependence of efficacy but not of safety in sublingual immunotherapy.Monaldi Arch Chest Dis,2006,65:38-40. |
24. | Cox LS,Linnemann DL,Nolte H,et al.Sublingual immunotherapy:a comprehensive review.J Allergy Clin Immunol,2006,117:1021-1035. |
25. | Penagos M,Compalati E,Tarantini F,et al.Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age:a meta-analysis of randomized,placebo-controlled,double-blind trials.Ann Allergy Asthma Immunol,2006,97:141-148. |
26. | Lue KH,Lin YH,Sun HL,et al.Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites:a double-blind,randomized,placebo-controlled study.Pediatr Allergy Immunol,2006,17:408-415. |
27. | Gidaro GB,Marcucci F,Sensi L,et al.The safety of sublingual-swallow immunotherapy:an analysis of published studies.Clin Exp Allergy,2005,35:565-571. |
28. | Rienzo VD,Minelli M,Musarra A,et al.Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years.Clin Exp Allergy,2005,35:560-564. |
29. | Fiocchi A,Pajno G,La Grutta S,et al.Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years.Ann Allergy Asthma Immunol,2005,95:254-258. |
30. | Larsen TH,Poulsen LK,Melac M,et al.Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study.Allergy,2006,61:1173-1176. |
31. | Pajno GB,Peroni DG,Vita D,et al.Safety of sublingual immunotherapy in children with asthma.Paediatr Drugs,2003,5:777-781. |
32. | Pajno GB,Vita D,Caminiti L,et al.Children’s compliance with allergen immunotherapy according to administration routes.J Allergy Clin Immunol,2005,116:1380-1381. |
33. | Berto P,Bassi M,Incorvaia C,et al.Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.Allergy Immunol,2005,36:303-308. |
34. | Moingeon P,Batard T,Fadel R,et al.Immune mechanisms of allergen-specific sublingual immunotherapy.Allergy,2006,61:151-165. |
35. | Allam JP,Niederhagen B,Bucheler M,et al.Comparative analysis of nasal and oral mucosa dendritic cells.Allergy,2006,61:166-172. |
36. | Bahceciler NN,Arikan C,Taylor A,et al.Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites.Int Arch Allergy Immunol,2005,136:287-294. |
37. | Cosmi L,Santarlasci V,Angeli R,et al.Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.Clin Exp Allergy,2006,36:261-272. |
38. | Akdis M,Verhagen J,Taylor A,et al.Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.J Exp Med. 2004,199:1567-1575. |
39. | Ciprandi G,Fenoglio D,Cirillo I,et al.Induction of interleukin 10 by sublingual immunotherapy for house dust mites:a preliminary report.Ann Allergy Asthma Immunol,2005,95:38-44. |
40. | Ippoliti F,De Santis W,Volterrani A,et al.Immunomodulation during sublingual therapy in allergic children.Pediatr Allergy Immunol,2003,14:216-221. |
41. | Marcucci F,Sensi L,Frati F,et al.Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy(SLIT):safety and immunologic implications.Allergy,2001,56:1091-1095. |
42. | Marcucci F,Sensi L,Frati F,et al.Effects on inflammation parameters of a double-blind,placebo controlled one-year course of SLIT in children monosensitized to mites.Allergy,2003,58:657-662. |
43. | Silverstri M,Spallarossa D,Battistini F,et al.Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy.J Investig Allergol Clin Immunol,2002,12:52-59. |
44. | Allam JP,Novak N,Fuchs C,et al.Characterization of dendritic cells from human oral mucosa:a new Langerhans’ cell type with high constitutive FcepsilonRI expression.J Allergy Clin Immunol,2003,112:141-148. |
45. | 程相铎,梅海豫,胡光荣.口服螨液免疫治疗过敏性哮喘.临床军医杂志,2003,31:18-19. |
46. | 赵京,陈育智,丁燕,等.口服螨免疫疗法辅助治疗儿童哮喘疗效观察.中国实用儿科杂志,1999,14:661-663. |
47. | 程志英,汪新,王国洪,等.变应原疫苗雾化吸入对支气管哮喘患者Th1/Th2细胞因子平衡的调控.临床耳鼻喉科杂志,2006,20:790-792. |
- 1. Passalacqua G,Guerra L,Pasquali M,et al.Efficacy and safety of sublingual immunotherapy.Ann Allergy Asthma Immunol,2004,93:3-12.
- 2. Bagnasco M,Passalacqua G,Villa G,et al.Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers.Clin Exp Allergy,2001,31:54-60.
- 3. Walker GF,Langoth N,Bernkop-Schnürch A.Peptidase activity on the surface of the porcine buccal mucosa,2002,233:141-147.
- 4. Bousquet J,Van Cauwenberge P,Khaltaev N,et al.Allergic rhinitis and its impact on asthma.J Allergy Clin Immunol,2001,108:S147-334.
- 5. Wilson DR,Lima MT,Durham SR.Sublingual immunotherapy for allergic rhinitis:systematic review and meta-analysis.Allergy,2005,60:4-12.
- 6. Lowenstein H,LarsenJN.Recombinant allergens/allergen standardization.Curr Allergy Asthma Rep,2001,1:474-479.
- 7. Moingeon P.Sublingual immunotherapy:from biological extracts to recombinant allergens.Allergy,2006,Suppl 81:15-19.
- 8. Baena-Cagnani CE,Passalacqua G,Baena-Cagnani RC,et al.Sublingual immunotherapy in pediatric patients:beyond clinical efficacy.Curr Opin Allergy Clin Immunol.2005,5:173-177.
- 9. Pajno GB,Morabito L,Barberio G,et al.Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites:a double-blind,placebo-controlled study.Allergy,2000,55:842-849.
- 10. Ippoliti F,De Santis W,Volterrani A,et al.Immunomodulation during sublingual therapy in allergic children.Pediatr Allergy Immunol,2003,14:216-221.
- 11. Rolinck-Werninghaus C,Wolf H,Liebke C,et al.A prospective,randomized,double-blind,placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy(SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.Allergy,2004,59:1285-1293.
- 12. Novembre E,Galli E,Landi F,et al.Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.J Allergy Clin Immunol,2004,114:851-857.
- 13. Di Rienzo V,Marcucci F,Puccinelli P,et al.Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite:a 10-year prospective study.Clin Exp Allergy,2003,33:206-210.
- 14. Tonnel AB,Scherpereel A,Douay B,et al.Allergic rhinitis due to house dust mites:evaluation of the efficacy of specific sublingual immunotherapy.Allergy,2004,59:491-497.
- 15. Berto P,Passalacqua G,Crimi N,et al.Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy:the Sublingual Immunotherapy Pollen Allergy Italy(SPAI) study.Ann Allergy Asthma Immunol,2006,97:615-621.
- 16. Calamita Z,Saconato H,Pela AB,et al.Efficacy of sublingual immunotherapy in asthma:systematic review of randomized-clinical trials using the Cochrane Collaboration method.Allergy,2006,61:1162-1172.
- 17. Malling HJ.Sublingual immunotherapy:efficacy--methodology and outcome of clinical trials.Allergy,2006,Suppl 81:24-28.
- 18. Wilson DR,Torres LI,Durham SR.Sublingual immunotherapy for allergic rhinitis(Cochrane review).Cochrane Database Syst Rev,2003,CD002893.
- 19. Marogna M,Bruno M,Massolo A,Falagiani P.Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity:A long-term(13-year) retrospective study in real life.Int Arch Allergy Immunol,2007,142:70-78.
- 20. Bordignon V,Burastero SE.Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis.Ann Allergy Asthma Immunol,2006,97:158-163.
- 21. Savolainen J,Jacobsen L,Valovirta E.Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.Allergy,2006,61:1184-1190.
- 22. Valovirta E,Jacobsen L,Ljørring C,et al.Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.Allergy,2006,61:1177-1183.
- 23. Frati F,Incorvaia C,Marcucci F,et al.Dose dependence of efficacy but not of safety in sublingual immunotherapy.Monaldi Arch Chest Dis,2006,65:38-40.
- 24. Cox LS,Linnemann DL,Nolte H,et al.Sublingual immunotherapy:a comprehensive review.J Allergy Clin Immunol,2006,117:1021-1035.
- 25. Penagos M,Compalati E,Tarantini F,et al.Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age:a meta-analysis of randomized,placebo-controlled,double-blind trials.Ann Allergy Asthma Immunol,2006,97:141-148.
- 26. Lue KH,Lin YH,Sun HL,et al.Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites:a double-blind,randomized,placebo-controlled study.Pediatr Allergy Immunol,2006,17:408-415.
- 27. Gidaro GB,Marcucci F,Sensi L,et al.The safety of sublingual-swallow immunotherapy:an analysis of published studies.Clin Exp Allergy,2005,35:565-571.
- 28. Rienzo VD,Minelli M,Musarra A,et al.Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years.Clin Exp Allergy,2005,35:560-564.
- 29. Fiocchi A,Pajno G,La Grutta S,et al.Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years.Ann Allergy Asthma Immunol,2005,95:254-258.
- 30. Larsen TH,Poulsen LK,Melac M,et al.Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study.Allergy,2006,61:1173-1176.
- 31. Pajno GB,Peroni DG,Vita D,et al.Safety of sublingual immunotherapy in children with asthma.Paediatr Drugs,2003,5:777-781.
- 32. Pajno GB,Vita D,Caminiti L,et al.Children’s compliance with allergen immunotherapy according to administration routes.J Allergy Clin Immunol,2005,116:1380-1381.
- 33. Berto P,Bassi M,Incorvaia C,et al.Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.Allergy Immunol,2005,36:303-308.
- 34. Moingeon P,Batard T,Fadel R,et al.Immune mechanisms of allergen-specific sublingual immunotherapy.Allergy,2006,61:151-165.
- 35. Allam JP,Niederhagen B,Bucheler M,et al.Comparative analysis of nasal and oral mucosa dendritic cells.Allergy,2006,61:166-172.
- 36. Bahceciler NN,Arikan C,Taylor A,et al.Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites.Int Arch Allergy Immunol,2005,136:287-294.
- 37. Cosmi L,Santarlasci V,Angeli R,et al.Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.Clin Exp Allergy,2006,36:261-272.
- 38. Akdis M,Verhagen J,Taylor A,et al.Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.J Exp Med. 2004,199:1567-1575.
- 39. Ciprandi G,Fenoglio D,Cirillo I,et al.Induction of interleukin 10 by sublingual immunotherapy for house dust mites:a preliminary report.Ann Allergy Asthma Immunol,2005,95:38-44.
- 40. Ippoliti F,De Santis W,Volterrani A,et al.Immunomodulation during sublingual therapy in allergic children.Pediatr Allergy Immunol,2003,14:216-221.
- 41. Marcucci F,Sensi L,Frati F,et al.Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy(SLIT):safety and immunologic implications.Allergy,2001,56:1091-1095.
- 42. Marcucci F,Sensi L,Frati F,et al.Effects on inflammation parameters of a double-blind,placebo controlled one-year course of SLIT in children monosensitized to mites.Allergy,2003,58:657-662.
- 43. Silverstri M,Spallarossa D,Battistini F,et al.Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy.J Investig Allergol Clin Immunol,2002,12:52-59.
- 44. Allam JP,Novak N,Fuchs C,et al.Characterization of dendritic cells from human oral mucosa:a new Langerhans’ cell type with high constitutive FcepsilonRI expression.J Allergy Clin Immunol,2003,112:141-148.
- 45. 程相铎,梅海豫,胡光荣.口服螨液免疫治疗过敏性哮喘.临床军医杂志,2003,31:18-19.
- 46. 赵京,陈育智,丁燕,等.口服螨免疫疗法辅助治疗儿童哮喘疗效观察.中国实用儿科杂志,1999,14:661-663.
- 47. 程志英,汪新,王国洪,等.变应原疫苗雾化吸入对支气管哮喘患者Th1/Th2细胞因子平衡的调控.临床耳鼻喉科杂志,2006,20:790-792.